Dialysis Center Hemomed EOOD
- Address
- Bulevard Akad Ivan Evst Geshov 15, 1606 Sofia, Bulgaria
Dialysis Center Hemomed EOOD
Dialysis Center Hemomed EOOD is a specialized nephrology research facility dedicated to advancing treatment options for patients with end-stage renal disease and chronic kidney disease requiring dialysis. The center focuses on evaluating novel therapeutic interventions that address critical complications associated with long-term dialysis treatment, including anemia management and vascular access preservation.
- Anemia treatment in chronic kidney disease patients on hemodialysis
- Comparative efficacy studies of erythropoiesis-stimulating agents
- Prevention of arteriovenous graft thrombosis in dialysis patients
The center's research portfolio emphasizes improving quality of life and clinical outcomes for dialysis-dependent patients through participation in international clinical trials. Their expertise in managing dialysis populations enables comprehensive evaluation of hemoglobin level control strategies and vascular access complications, positioning them as a key contributor to nephrology research in renal replacement therapy and related complications management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Genexine Inc.2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Genexine Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dialysis Center Hemomed EOOD
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Efepoetin Alfa Versus Darbepoetin Alfa in Anemia Management for Chronic Kidney Disease Patients on Dialysis | Genexine Inc. | Phase III | Recruiting | Jul 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Darbepoetin Alfa | 2 | Unknown | 2025-07-22 | 2025-07-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.